Saturday, September 06, 2014 9:16:21 AM
1. Post ASCO, a lot of flippers cashed out 100% of their position, it will happen again with news, they troll around and do it to all the bios.
2. No news of p-ship which disappointed investors including me.
3. An offering at .71 which was timely for the corp. to move ahead with products but untimely for stock momentum.
4. Janet Yellen bashing small cap biotechs, it affected them all.
People got wise and are now buying back....it's looking like it will retest and likely pass the old highs, that usually is the norm with each passing phase gate success at any biotech.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM